We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves First Treatment For Genetic Clotting Disorder
FDA Approves First Treatment For Genetic Clotting Disorder
April 6, 2007
The FDA has approved Baxter’s Ceprotin, the first treatment for patients with a rare genetic blood clotting disorder.